Musculoskeletal
Approximately 1500 BCE, ancient Egyptian Ebers Papyrus (references to generalized musculoskeletal pain syndromes)
Fibromyalgia's historical journey stretched across centuries during which physicians struggled to define and categorize a constellation of pain-related complaints that defied easy anatomical explanation. Early healers attributed the condition to humoral imbalances, spiritual afflictions, and later to disorders of the nervous system. The formal recognition of fibromyalgia as a distinct clinical entity was a twentieth-century achievement built upon layers of contested and evolving medical thought.
Historical Narrative
The earliest recognizable descriptions of widespread musculoskeletal pain appeared in ancient Egyptian medical papyri, where scribes recorded ailments involving generalized bodily aching that resisted the standard remedies of the era. Physicians of antiquity, working within humoral frameworks inherited from Greek medicine, attributed such persistent pain to an excess of black bile or to cold, damp humors lodging within the muscles and connective tissues. Hippocratic writers grouped many such complaints under broad categories of rheumatism, a term derived from the Greek word for flowing, reflecting the belief that noxious fluids migrated through the body and settled painfully in soft tissues.
Galen of Pergamon, the enormously influential second-century physician whose writings dominated European medicine for over a millennium, elaborated on these humoral explanations and proposed that fibrous tissues were particularly vulnerable to cold and moisture. His frameworks meant that treatments for centuries centered on warming therapies, purges, and dietary corrections intended to restore humoral equilibrium. Medieval Islamic physicians, including Ibn Sina, whose Canon of Medicine was studied across Europe and the Arab world, similarly catalogued pain syndromes involving muscles and joints under categories that blended Greek theory with careful clinical observation.
The seventeenth and eighteenth centuries brought renewed intellectual interest in classifying disease. Guillaume de Baillou, a French physician often credited as a founder of epidemiology, attempted to systematize rheumatic conditions in the sixteenth and early seventeenth centuries, distinguishing between joint-based and soft-tissue forms of pain. His work laid groundwork for later investigators who would try to separate what was happening in bones and joints from what was happening in muscles and fibrous structures.
A pivotal moment in the condition's conceptual history came in 1816, when Scottish physician William Balfour offered what many historians regard as a recognizable early description of the tender points and diffuse muscular pain that would later define the condition. Balfour proposed that nodular thickenings within muscle tissue were responsible for the pain, a hypothesis that directed attention toward the physical substance of muscle rather than circulating humors.
In 1904, British neurologist Sir William Gowers introduced the term fibrositis, suggesting that inflammation of fibrous tissue was the underlying cause. The fibrositis concept dominated medical thinking for decades and shaped treatment approaches that included massage, heat, and later physical manipulation. However, subsequent investigators who examined muscle tissue under microscopes found no consistent inflammatory changes, and the fibrositis hypothesis gradually lost scientific credibility through the mid-twentieth century.
During the 1970s and 1980s, researchers including Hugh Smythe and Harvey Moldofsky conducted systematic studies that repositioned the condition as a disorder involving pain processing and sleep disturbance rather than peripheral tissue inflammation. Smythe's work on tender point mapping and Moldofsky's investigations into sleep physiology together shifted the dominant explanatory model dramatically. In 1990, the American College of Rheumatology published classification criteria that formalized the diagnosis, marking the culmination of a centuries-long effort to give the condition a stable, recognized identity within medicine.
Key Historical Figures
Historical narrative only — this page describes how Fibromyalgia was understood historically. It is not medical advice and does not describe current diagnosis or treatment. Sourced from verified medical history references (NIH, Encyclopaedia Britannica, and standard medical history texts). See our medical disclaimer.